全文获取类型
收费全文 | 3159296篇 |
免费 | 231339篇 |
国内免费 | 4763篇 |
专业分类
耳鼻咽喉 | 44850篇 |
儿科学 | 104991篇 |
妇产科学 | 85882篇 |
基础医学 | 459079篇 |
口腔科学 | 86801篇 |
临床医学 | 284177篇 |
内科学 | 611750篇 |
皮肤病学 | 69648篇 |
神经病学 | 249564篇 |
特种医学 | 120003篇 |
外国民族医学 | 1096篇 |
外科学 | 477583篇 |
综合类 | 67353篇 |
现状与发展 | 12篇 |
一般理论 | 1119篇 |
预防医学 | 246846篇 |
眼科学 | 74028篇 |
药学 | 235452篇 |
12篇 | |
中国医学 | 6139篇 |
肿瘤学 | 169013篇 |
出版年
2019年 | 24981篇 |
2018年 | 34785篇 |
2017年 | 26151篇 |
2016年 | 29280篇 |
2015年 | 33021篇 |
2014年 | 46527篇 |
2013年 | 70296篇 |
2012年 | 96783篇 |
2011年 | 103022篇 |
2010年 | 61458篇 |
2009年 | 58150篇 |
2008年 | 97093篇 |
2007年 | 103738篇 |
2006年 | 104670篇 |
2005年 | 101408篇 |
2004年 | 97691篇 |
2003年 | 94259篇 |
2002年 | 91751篇 |
2001年 | 144754篇 |
2000年 | 148994篇 |
1999年 | 126081篇 |
1998年 | 36522篇 |
1997年 | 32176篇 |
1996年 | 32561篇 |
1995年 | 30889篇 |
1994年 | 28719篇 |
1993年 | 26835篇 |
1992年 | 98553篇 |
1991年 | 96559篇 |
1990年 | 93998篇 |
1989年 | 90214篇 |
1988年 | 83040篇 |
1987年 | 81825篇 |
1986年 | 76472篇 |
1985年 | 73601篇 |
1984年 | 55013篇 |
1983年 | 46713篇 |
1982年 | 27729篇 |
1981年 | 24980篇 |
1979年 | 50368篇 |
1978年 | 35731篇 |
1977年 | 30013篇 |
1976年 | 28484篇 |
1975年 | 30773篇 |
1974年 | 36490篇 |
1973年 | 34924篇 |
1972年 | 32576篇 |
1971年 | 30487篇 |
1970年 | 28420篇 |
1969年 | 26749篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
141.
Debra L. Roter Richard M. Frankel Judith A. Hall David Sluyter 《Journal of general internal medicine》2006,21(1):28-34
Relationship-centered care reflects both knowing and feeling: the knowledge that physician and patient bring from their respective domains of expertise, and the physician’s and patient’s experience, expression, and perception of emotions during the medical encounter. These processes are conveyed and reciprocated in the care process through verbal and nonverbal communication. We suggest that the emotional context of care is especially related to nonverbal communication and that emotion-related communication skills, including sending and receiving nonverbal messages and emotional self-awareness, are critical elements of high-quality care. Although nonverbal behavior has received far less study than other care processes, the current review argues that it holds significance for the therapeutic relationship and influences important outcomes including satisfaction, adherence, and clinical outcomes of care. 相似文献
142.
143.
OBJECTIVE: To compare infants' discomfort, nursing-time and caregiver preference, and assess the clinical efficiency (as a secondary outcome) of hood versus facemask nebulization in infants with evolving bronchopulmonary dysplasia (BPD) in the neonatal intensive care unit. STUDY DESIGN: A prospective, open, randomized, controlled crossover clinical trial. In total, 10 infants with BPD who were on inhaled beta-agonist bronchodilators and corticosteroids were randomly assigned to receive their nebulized treatments either by a facemask, or by a hood for 2-3 days, and then crossover to receive the same treatments with the other technique for another 2-3 days. Infants' discomfort, nursing-time, caregiver preference and clinical efficiency were compared. RESULTS: At baseline there was no significant clinical difference between the groups. Nurse-time required for administering the hood nebulization (mean+/-s.e.m.: 1.9+/-0.1 min) was significantly shorter than the time for mask nebulization (12.0+/-0.6 min, P<0.0001). Infants' discomfort score was significantly lower (0.1+/-0.04) for hood versus mask nebulization (2.5+/-0.2, P<0.0001). Nurses and parents unequivocally preferred the hood treatment. During both mask and hood nebulization therapies (2-3 days) clinical efficiency was comparable. While both methods caused an immediate (20 min post) clinical improvement, the immediate respiratory assessment change score was significantly greater for the hood versus the mask nebulization (0.62+/-0.27 versus 0.13+/-0.14, P<0.05). CONCLUSIONS: Nebulization of aerosolized medications in infants with evolving BPD by hood was less time-consuming for caregivers and was much better tolerated by the infants while being at least as effective as the conventional facemask nebulization. 相似文献
144.
Andrea R Genazzani Hermann P G Schneider Nick Panay Esme A Nijland 《Gynecological endocrinology》2006,22(7):369-375
OBJECTIVES: To identify and describe current women's thoughts about the menopause, hormone treatment (HT) and perceptions about breast cancer. METHODS: Between December 2004 and January 2005, 4201 postmenopausal women in seven European countries were interviewed via a standardized computer-aided telephone interview protocol. RESULTS: Almost all women reported to have experienced climacteric symptoms, and 63% of the women rated them as being severe. Only 52% of women were aware of the benefits of HT for relief of climacteric symptoms. Although 84% felt that severe symptoms should be treated, only 40% had used HT at some point in time. Thirty-four percent of the women preferring treatment with natural products did so because of the risk of breast cancer associated with HT. HT was recognized by 59% of the women as one of the most important contributors to an increased breast cancer risk. Most women received their information about HT and breast cancer risk from the media. CONCLUSIONS: This European survey reveals that the majority of women experience climacteric symptoms but that their decision whether or not to use HT is highly dependent on their concern about breast cancer risk. An increase in knowledge of the benefits and risks of HT is required for women to make appropriate decisions about hormone use. 相似文献
145.
A Gyang S Mirando 《The European journal of contraception & reproductive health care》2006,11(4):319-321
A 41-year-old Chinese lady had a Gr?fenberg ring in utero for 15 years. During that period of time, she had one normal vaginal delivery a year after insertion, followed by an ectopic pregnancy 12 years later. We discuss the possible mechanism of action of the Gr?fenberg ring and sequelae of its prolonged presence in the uterus. 相似文献
146.
Elhaji Youssef A.; Stoica Ileana; Dennis Sheldon; Purisima Enrico O.; Lumbroso Rose; Beitel Lenore K.; Trifiro Mark A. 《Human molecular genetics》2006,15(9):1561
Human Molecular Genetics (2006) 15, 921931; 相似文献
147.
148.
C G Arruda J M Aldrighi L A Bortolotto I N Alecrin J A F Ramires 《Gynecological endocrinology》2006,22(10):557-563
BACKGROUND: Arterial hypertension and postmenopausal reduction of estrogen levels may be involved in modifications of the stiffness of large arteries. OBJECTIVES: To evaluate the pulse-wave velocity (PWV) and indirectly the arterial stiffness in hypertensive postmenopausal women submitted to hormone therapy with estradiol alone or combined with norethisterone acetate. SUBJECTS: Forty-five hypertensive postmenopausal women were double-blindly, randomly assigned to three arms of treatment: placebo (group I); estradiol 2 mg/day (group II); or estradiol 2 mg/day and norethisterone acetate 1 mg/day (group III). METHODS: Arterial stiffness was assessed from PWV measurements of the common carotid and femoral arteries (CF-PWV) and the common carotid and radial arteries (CR-PWV) obtained using the automatic Complior(R) device, taken at baseline and after 12 weeks of treatment. RESULTS: After the 12-week treatment, values of CF-PWV and CR-PWV were not significantly different (p = 0.910 and p = 0.736, respectively) among the groups. Systolic blood pressure showed a positive correlation with CF-PWV in groups II and III (p = 0.02 and p < 0.001, respectively). CONCLUSIONS: PWV and arterial stiffness in postmenopausal hypertensive women did not reduce over a 12-week treatment with estradiol alone compared with the same period of treatment with estradiol combined with norethisterone acetate. 相似文献
149.
The aim of our study was to determine the incidence, timing, and severity of vaginal stenosis in patients with carcinoma of the cervix who had received pelvic and/or vaginal radiotherapy as part of their treatment. We also sought to determine if there were any predisposing factors for the development of stenosis. A retrospective chart review was undertaken for all the patients diagnosed with carcinoma of the cervix between January 1, 1990, and December 31, 2000 and treated with pelvic and/or vaginal radiation at Westmead Hospital. Since January 1, 1990, data regarding vaginal stenosis has been prospectively recorded on all the patients. Data collected included patient demographics, stage of disease, treatments administered, and incidence, timing, and severity of vaginal stenosis. One hundred and eighty-eight patients were treated. Mean age was 58.6 years. Thirteen percent of patients had stage IB disease, 45% had stage II disease, 39.5% had stage III disease, and 1.5% had stage IV disease. One hundred and seventy-nine patients returned for follow-up, and data regarding vaginal toxicity were available in 98%. Twenty-seven percent had grade 1 toxicity (partial stenosis or shortening but not complete occlusion), and 11% had grade 2 (complete occlusion). Stenosis of any grade was noted at a mean of 9.6 months and median of 7.5 months (range, 26 days-5.6 years) from completion of treatment. The only prognostic factor associated with increased risk of stenosis was age greater than 50 years (odds ratio 2.26). Vaginal stenosis is a common complication of pelvic and vaginal radiotherapy, occurring in 38% of patients. Stenosis occurs most often in the first year after treatment. Patients over the age of 50 are most at risk. 相似文献
150.